Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Enzo loses US probe patent case, seeks new hearing

This article was originally published in Clinica

Executive Summary

Diagnostics and healthcare products manufacturer Enzo Biochem has lost its US patent case, in which is was claiming that San Diego-based Gen-Probe's Neisseria gonorrhoeae nucleic acid probe diagnostic infringed its patent. The case, launched by Enzo in 1999, was resolved last week when judges at the US Court of Appeal decided 2-to-1 that the Enzo patent was invalid for lack of written description of the claimed invention. The decision confirmed an earlier lower court ruling.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT066005

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel